Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficient and safe glycaemic control with basal-bolus insulin therapy during fasting periods in hospitalized patients with type 2 diabetes using decision support technology: A post hoc analysis.
Hochfellner DA, Rainer R, Ziko H, Aberer F, Simic A, Lichtenegger KM, Beck P, Donsa K, Pieber TR, Fruhwald FM, Rosenkranz AR, Kamolz LP, Baumann PM, Mader JK, Plank J. Hochfellner DA, et al. Among authors: rosenkranz ar. Diabetes Obes Metab. 2021 Sep;23(9):2161-2169. doi: 10.1111/dom.14458. Epub 2021 Jun 22. Diabetes Obes Metab. 2021. PMID: 34081386
Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards.
Neubauer KM, Mader JK, Höll B, Aberer F, Donsa K, Augustin T, Schaupp L, Spat S, Beck P, Fruhwald FM, Schnedl C, Rosenkranz AR, Lumenta DB, Kamolz LP, Plank J, Pieber TR. Neubauer KM, et al. Among authors: rosenkranz ar. Diabetes Technol Ther. 2015 Oct;17(10):685-92. doi: 10.1089/dia.2015.0027. Epub 2015 Jun 5. Diabetes Technol Ther. 2015. PMID: 26355756 Free PMC article.
Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation.
Moschovaki Filippidou F, Kirsch AH, Thelen M, Kétszeri M, Artinger K, Aringer I, Schabhüttl C, Mooslechner AA, Frauscher B, Pollheimer M, Niedrist T, Meinitzer A, Drucker DJ, Pieber TR, Eller P, Rosenkranz AR, Heinemann A, Eller K. Moschovaki Filippidou F, et al. Among authors: rosenkranz ar. Am J Pathol. 2020 Feb;190(2):400-411. doi: 10.1016/j.ajpath.2019.10.008. Epub 2019 Nov 22. Am J Pathol. 2020. PMID: 31759969 Free article.
Chronic Inflammation Might Protect Hemodialysis Patients From Severe COVID-19.
Prietl B, Odler B, Kirsch AH, Artinger K, Eigner M, Schmaldienst S, Pfeifer V, Stanzer S, Eberl A, Raml R, Pieber T, Rosenkranz AR, Brodmann M, Eller P, Eller K. Prietl B, et al. Among authors: rosenkranz ar. Front Immunol. 2022 Feb 21;13:821818. doi: 10.3389/fimmu.2022.821818. eCollection 2022. Front Immunol. 2022. PMID: 35265078 Free PMC article.
Early Postoperative Basal Insulin Therapy versus Standard of Care for the Prevention of Diabetes Mellitus after Kidney Transplantation: A Multicenter Randomized Trial.
Schwaiger E, Krenn S, Kurnikowski A, Bergfeld L, Pérez-Sáez MJ, Frey A, Topitz D, Bergmann M, Hödlmoser S, Bachmann F, Halleck F, Kron S, Hafner-Giessauf H, Eller K, Rosenkranz AR, Crespo M, Faura A, Tura A, Song PXK, Port FK, Pascual J, Budde K, Ristl R, Werzowa J, Hecking M. Schwaiger E, et al. Among authors: rosenkranz ar. J Am Soc Nephrol. 2021 Aug;32(8):2083-2098. doi: 10.1681/ASN.2021010127. J Am Soc Nephrol. 2021. PMID: 34330770 Free PMC article. Clinical Trial.
The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.
Watschinger B, Salmhofer H, Horn S, Neyer U, Wiesinger T, Wiesholzer M, Erb H, Jaeger C, Hemetsberger M, Rosenkranz AR. Watschinger B, et al. Among authors: rosenkranz ar. Wien Klin Wochenschr. 2013 Feb;125(3-4):71-82. doi: 10.1007/s00508-012-0311-1. Epub 2013 Jan 9. Wien Klin Wochenschr. 2013. PMID: 23299452 Clinical Trial.
251 results